Currently Accepting Nominations
This page serves as the designated site that is used to solicit nominations for technical expert panel members for CMS measure development and maintenance contractors. Individuals with expertise in the relevant fields including clinicians, statisticians, quality improvement, methodologists, and pertinent measure developers, as well as consumers, are encouraged to submit nominations. Person and family membership on TEPs is a very important part of the measure development process. TEP members are chosen to provide input to the measure contractor based on their personal experience and training. It is critical to the success that TEP members represent a diversity of perspectives and backgrounds.
TEPs Accepting Nominations:
- 2018 Merit-based Incentive Payment System (MIPS) Improvement Activities (IA) Technical Expert Panel (TEP)
- MACRA Episode-Based Cost Measures - Call for Clinical Subcommittee
Project Title: 2018 Merit-based Incentive Payment System (MIPS) Improvement Activities (IA) Technical Expert Panel (TEP)
The TEP nomination period opens on August 22, 2018 and closes on September 21, 2018. Please submit all nomination materials by close of business (5:00 pm PT) on the closing date.
The Centers for Medicare & Medicaid Services (CMS) has contracted with General Dynamics Information Technology (GDIT), through the Practice Improvement and Measures Management Support (PIMMS) contract – HHSM-500-2013-13008I, HHSM-500-T0001, to convene a technical expert panel (TEP) around the effectiveness and accuracy of the improvement activities (IAs) included in year 2 of the Quality Payment Program under the Merit-based Incentive Payment System’s (MIPS) Improvement Activities performance category. HealthInsight is the sub-contractor for this aspect of the project.
As part of its improvement activity development process, CMS is convening a group of stakeholders, consumers, patients and experts who can contribute direction and thoughtful input to the improvement activity developers during improvement activity development and maintenance.
HealthInsight, through its contract with GDIT and CMS, will convene a TEP around the effectiveness and accuracy of the IAs included in year 2 of the Quality Payment Program under the MIPS Improvement Activities performance category. The TEP will perform a review of selected IAs, especially those about which the Quality Payment Program Service Center has been receiving comments and questions. The purpose is to:
- Engage users in the design of these IAs;
- Solicit feedback on the IAs with those using them in the real world; and
- Ensure that IAs are valid, weighted correctly, and that their qualifications/criteria make sense.
We are seeking a TEP of approximately 10-12 clinicians and individuals with the following perspectives and areas of expertise:
Subject matter/clinical expertise with IAs
Consumer/patient/family (non-medical caregiver) perspective
Healthcare disparities knowledge
Potential TEP members must be aware that participation on the TEP is voluntary. As such, individuals wishing to participate on the TEP should understand that their input would be recorded in the meeting minutes. Proceedings of the TEP will be summarized in a report that is disclosed to the public. If a participant has disclosed private, personal data by his or her own choice, then that material and those communications are not deemed to be covered by patient-provider confidentiality. If patient participants (only) wish to keep their names confidential, that request can be accommodated. Any questions about confidentiality will be answered by the TEP organizers.
All potential TEP members must disclose any current and past activities that may pose a potential conflict of interest for performing the tasks required of the TEP. All potential TEP members should be able to commit to the anticipated time frame needed to perform the functions of the TEP.
Consumer/Patient/Family (Non-Medical Caregiver) Nominees:
HealthInsight is seeking patients, patient family members and/or non-medical caregivers to participate on this TEP. Those who would like to share their perspective or experience with the IAs are encouraged to join the TEP and provide their unique perspectives. Patients, patient family members and/or non-medical caregivers are valuable to this process as they can provide an essential viewpoint that can further inform this work.
Patient, patient family member, and/or non-medical caregiver nominees should submit a completed and signed TEP Nomination Form and letter of interest as described below, but are not required to submit curriculum vitae.
TEP Expected Time Commitment:
The TEP meeting will be conducted via a virtual meeting platform. As this TEP will inform the rulemaking process, this nomination will be held annually, and participants will only need to attend one meeting, although there may be additional pre-meeting work and follow-up discussions. The length of this meeting is approximately 120 minutes. Additional self-directed meeting preparation time could run approximately 3-4 hours.
A completed and signed TEP Nomination form located in the download section below.
The nomination form includes a consent and confidentiality statement.
A letter of interest (not to exceed two pages) highlighting experience/knowledge relevant to the IA review outlined above and describing the interest in being involved in an IA-related TEP.
Curriculum vitae or a summary of relevant experience (maximum of 10 pages).
NOTE: Patient participants are not required to submit a curriculum vitae and may elect to keep their names confidential in public documents.
The Nomination Form template and proposed TEP Charter are found in the download section below.
If you wish to nominate yourself, or other individuals for consideration, please complete the Nomination Form and include it with the other required materials in an email to: ImprovementActivityTEP@healthinsight.org. Include “Nomination” in the subject line.
Dates:The nomination period for ten Clinical Subcommittees active during Wave 2 of measure development opened on February 6, 2018 and closed on March 20, 2018 at midnight ET. To be considered for the first in-person meeting, all nomination materials were to be submitted before the closing date. We will, however, continue to accept nominations on a continuous basis after this date; nominees who submit their information after this date will enter a standing pool of nominees who may be selected for participation in condition- or procedure-specific workgroups convened within each Subcommittee.
The Centers for Medicare & Medicaid Services (CMS) has contracted with Acumen, LLC to develop care episode and patient condition groups for use in cost measures to meet the requirements of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The contract name is “MACRA Episode Groups and Cost Measures.” The contract number is HHSM-500-2013-13002I, Task Order HHSM-500-T00002. As part of its measure development process, CMS asks contractors to convene groups of stakeholders and experts who contribute direction and thoughtful input to the measure developer during cost measure development and maintenance.
The project’s overall objective is to develop episode-based cost measures suitable for potential use in the Quality Payment Program. In Wave 2, Acumen has reconvened six of the original seven Clinical Subcommittees that participated in Wave 1 in 2017 (excluding Ophthalmologic Disease Management) as well as four new Subcommittees to contribute to the development of episode-based cost measures: Musculoskeletal Disease Management - Spine; Oncologic Disease Management - Medical, Radiation, and Surgical; Renal Disease Management; and Urologic Disease Management.
The process for Clinical Subcommittee (CS) member involvement in measure development has been updated for Wave 2 based on the feedback we received from Subcommittee members during Wave 1 on Subcommittee size and composition. Accordingly, all members who submit their nomination materials by the deadline and who are accepted will attend the first in-person meeting and will be added to the Clinical Subcommittee. Nominees who submit their information after this date will enter a standing pool of nominees who may be selected for participation in condition- or procedure-specific workgroups convened within each Subcommittee.
The Clinical Subcommittee is a large body of clinicians that will meet during an in-person meeting in Washington D.C. to: (i) select which episode-based cost measure to develop, and (ii) discuss the desired composition of the workgroup that will build out the selected measure.
The Subcommittee may reconvene in future waves of measure development to provide input for additional cost measures within the Subcommittee’s clinical area.
Once each Subcommittee selects which measure to develop, we will then create a smaller measure-specific workgroup within each Clinical Subcommittee.
The workgroups will include 5-10 members (with a maximum of 15) whose specialty, expertise, or experience is aligned with the scope of the selected episode-based cost measure and the workgroup composition criteria discussed by the standing Subcommittee during the first in-person meeting.
The workgroups will be formed after the Clinical Subcommittee’s in-person meeting from within the membership of the Clinical Subcommittee at large as well as the standing pool of nominees where necessary.
Workgroup members will be expected to attend an additional in-person meeting in June 2018 (exact dates to be determined).
For additional information about the project background or about the Wave 2 Clinical Subcommittee nomination period, please see the additional materials within the “MACRA Episode-Based Cost Measures-Call for Clinical Subcommittee” ZIP file available in the Downloads section at the bottom of this CMS webpage (direct link also available on the nomination form here).
List of Subcommittees Participating in Wave 2:
The list below presents the Subcommittees that we are recruiting for through this Call for Nominations. Below each Subcommittee, we list the procedural and acute inpatient medical condition episode groups in that Subcommittee’s clinical area that have been previously recommended for development by clinical stakeholders. However, this list is not limiting; the Subcommittee may recommend additional episode groups.
- Cardiovascular Disease Management Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Acute Myocardial Infarction, Expired; Aortic Valve Procedure; Cardiac Arrhythmia & Conduction Disorders; Chest Pain; Coronary Artery Bypass Graft (CABG); Coronary Thrombectomy; Heart Failure & Shock; Implantable Cardiac Defibrillator (ICD) Implantation; Left Heart Catheterization; Mitral Valve Procedure; Pacemaker Implantation; Right Heart Catheterization; Supraventricular Tachycardia (SVT) Ablation; Syncope & Collapse; Thoracic Aortic Aneurysm Repair; Ventricular Tachycardia (VT) Ablation
- Gastrointestinal Disease Management - Medical and Surgical Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Cirrhosis & Alcoholic Hepatitis; Diagnostic Colonoscopy; Disorders Of The Biliary Tract; Esophagitis, Gastroent & Misc Digest Disorders; G.I. Hemorrhage; G.I. Obstruction; Hernia Repair (Femoral Or Inguinal); Hernia Repair (Incisional Or Ventral); Hiatal Hernia Repair; Major Gastrointestinal Disorders & Peritoneal Infections
- Musculoskeletal Disease Management - Non-Spine Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Ankle Fracture (No Dislocation); Bunionectomy; Femur Fracture Repair; Foot Fracture Or Dislocation; Fractures Of Hip & Pelvis; Hand Fracture Or Dislocation; Hip Arthroplasty; Humerus Fracture Repair; Knee Ligament Repair/Reconstruction; Meniscus Repair; Pelvic Fracture Repair/Treatment; Repair Of Arm Muscle Tendons (Not Including Rotator Cuff); Repair Of Foot Tendon/Ligament; Repair Of Hand Tendon/Ligament; Rotator Cuff Repair; Tibia Or Fibula Fracture Repair / Treatment; Toe Repair; Treatment of Hip Fracture/Dislocation; Treatment Of Shoulder Joint Or Clavicle Fracture/Dislocation; Wrist Fracture Treatment / Repair
- Musculoskeletal Disease Management - Spine Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Axial Decompression (Including Laminectomy); Spinal Fusion; Treatment of Spinal Fracture or Deformity
- Neuropsychiatric Disease Management Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Acute Ischemic Stroke W Use Of Thrombolytic Agent; Poisoning & Toxic Effects Of Drugs; Psychoses; Seizures; Transient Ischemia
- Oncologic Disease Management - Medical, Radiation, and Surgical Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Melanoma Resection; Lumpectomy or Partial Mastectomy; Simple or Modified Radical Mastectomy; Subcutaneous Mastectomy; Colonic Resection; Pancreatic Resection Excluding Pancreatic Cancer; Rectal Resection; Surgical Procedure for Gall Bladder Disease
- Peripheral Vascular Disease Management Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Abdominal Aortic Aneurysm Repair; Dialysis Access; Inferior Vena Cava Filter Placement; Procedure for Carotid Stenosis
- Pulmonary Disease Management Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Allergic Reactions; Bronchitis & Asthma; Chronic Obstructive Pulmonary Disease; Pleural Effusion; Pulmonary Edema & Respiratory Failure; Pulmonary Embolism; Respiratory Infections & Inflammations; Respiratory System Diagnosis W Ventilator Support <96 Hours; Respiratory System Diagnosis W Ventilator Support >96 Hours; Septicemia Or Severe Sepsis W Mv >96 Hours
- Renal Disease Management Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Endocrine Disorders; Kidney & Urinary Tract Infections; Other Kidney & Urinary Tract Diagnoses; Renal Failure
- Urologic Disease Management Clinical Subcommittee - This Subcommittee may contribute to the development of one or more of the following episode groups: Kidney Stone Removal or Destruction; Nephrectomy; Procedure for Benign Prostatic Hyperplasia; Prostate Cancer Treatment; Radical Cystectomy
All Subcommittee members who participated in Wave 1 in 2017 and are interested in continuing with Wave 2 of cost measure development must indicate their interest in an abbreviated nomination form shared directly with members via email. Existing members do not have to submit their nomination via the public nomination form. Please contact the Acumen measure development team if you did not receive an email.
Future Clinical Subcommittees
If you would like to be a part of a Clinical Subcommittee, but do not practice in any of the clinical areas we are recruiting for above, there will be future waves in which we convene additional Clinical Subcommittees. If you are interested in receiving updates regarding future Subcommittees, please provide your contact information on the MACRA Clinical Subcommittee Mailing List form.
List of Clinicians we are Recruiting:
Allergy/Immunology * Anesthesiology * Cardiac Electrophysiology * Cardiology * Certified Registered Nurse Anesthetist * Clinical Nurse Specialist * Clinical Psychologist * Colorectal Surgery * Critical Care (Intensivist) * Dentistry * Dermatology * Diagnostic Radiology * Emergency Medicine * Family Medicine * Gastroenterology * General Surgery * Geriatric Medicine * Hand Surgery * Hospitalists * Infectious Disease * Internal Medicine * Interventional Radiology * Interventional Cardiology * Licensed Clinical Social Worker * Mental/Behavioral Health * Nephrology * Neurology * Neurosurgical * Nurse Practitioner * Obstetrics/Gynecology * Occupational Therapy * Oncology * Orthopedic Surgery * Otolaryngology * Pathology * Pediatrics * Peripheral Vascular Disease * Physical Medicine and Rehabilitation * Physician Assistant * Plastic Surgery * Podiatry * Preventive Medicine * Psychologist * Psychiatrist * Pulmonary Disease * Radiation Oncology * Rheumatology * Speech Language Pathologist * Sports Medicine * Surgical Oncology * Thoracic Surgery * Urology * Vascular Surgery
Desired Qualifications of Clinical Subcommittee Members:
- Medical credentials relevant to the types of clinicians listed above
- Familiarity with medical coding (ICD-10, HCPCS/CPT, DRG)
- Board-certified or other professional certifications, as applicable
- Experience treating Medicare patients
Tasks and Expected Time Commitment for Clinical Subcommittee Members:
Tasks for All Clinical Subcommittee Members
2-4 hours to review Welcome Packet
1 in-person meeting lasting about 4 hours, for all CS members for episode group selection in downtown Washington, D.C. in April 2018 (exact dates for each Subcommittee can be found on the nomination form here after February 9) (plus travel time)
*Expected Time Commitment for Clinical Subcommittee Members who attend first in-person meeting = about 1.5 days total
Tasks for Workgroup Members Only
1 day-long in-person meeting for workgroup members only for episode group specification in downtown Washington, D.C. in May/June (exact dates to be determined) (plus travel time)
2-4 hours to prepare for Service Assignment and Risk Adjustment Webinar
2 hour Service Assignment and Risk Adjustment Webinar
2-4 hours to prepare for Refinement Webinar
2 hour Refinement Webinar
*Expected Time Commitment for Workgroup Members Only = about 3 days total
Nominees are required to submit a completed MACRA Clinical Subcommittee Nomination Form. As part of this form, nominees are required to upload (i) a letter of interest (not to exceed two pages) highlighting experience/knowledge relevant to the expertise described above and involvement in measure development, and (ii) a curriculum vitae or summary of relevant experience (not to exceed 10 pages). If you wish to nominate yourself or other individuals for consideration, please complete the form by March 20, 2018 at midnight ET to be considered for participation in Wave 2. Nominees who submit their information after this date will enter a standing pool of nominees who may be selected for participation in condition- or procedure-specific workgroups convened within each Subcommittee.
If you have any questions about the Clinical Subcommittees, the nomination process, or this project generally, please email firstname.lastname@example.org. If you would like to receive a 508-compliant PDF version of the nomination form for submission via email instead of the web-based form linked above, please email email@example.com to receive a blank form.
- 2018 Merit-based Incentive Payment System (MIPS) Improvement Activities (IA) Technical Expert Panel (TEP) [ZIP]
- MACRA Episode-Based Cost Measures - Call for Clinical Subcommittee[ZIP]
- Page last Modified: 08/15/2018 2:57 PM
- Help with File Formats and Plug-Ins